Nitrosamines: Where Are We Now?
Рет қаралды 3,239
Күн бұрынFDA discusses the agency’s current thinking on nitrosamine risk mitigation.
Presenter:
Deborah F. Johnson, Branch Chief, Division of Lifecycle API, Office of New Drug Products (ONDP) | Office of Pharmaceutical Quality (OPQ) | CDER
Learn more at: www.fda.gov/dr...
--------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2021 Playlist - • 2021 CDER Small Busine...
SBIA LinkedIn: / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter - / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
U.S. Food and Drug Administration
Рет қаралды 2,9 М.
U.S. Food and Drug Administration
Рет қаралды 7 М.
Daniel LaBelle
Рет қаралды 150 МЛН
U.S. Food and Drug Administration
Рет қаралды 363
U.S. Food and Drug Administration
Рет қаралды 2,2 М.
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
U.S. Food and Drug Administration
Рет қаралды 375
U.S. Food and Drug Administration
Рет қаралды 734
U.S. Food and Drug Administration
Рет қаралды 595
U.S. Food and Drug Administration
Рет қаралды 1,6 М.
U.S. Food and Drug Administration
Рет қаралды 878
U.S. Food and Drug Administration
Рет қаралды 552
U.S. Food and Drug Administration
Рет қаралды 745